Yet, the present findings reinforce the usefulness of this II in assessing the changes occurring in patients affected by the MetS the insulin secretory response of the endocrine pancreas to extracellular glucose considered as the major regulator of insulin secretion. This evidence concerns the gene INS and metabolic syndrome.